_id
695fbb8fc2e91020a7bd436d
Ticker
0K6R.LSE
Name
Neurocrine Biosciences, Inc.
Exchange
LSE
Address
12780 El Camino Real, San Diego, CA, United States, 92130
Country
UK
Sector
Industry
Currency
USD
Website
https://www.neurocrine.com
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy and schizophrenia; NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Last Close
138.13
Volume
171
Current Price
139.73
Last Updated
2026-01-08T14:13:35.546Z
Ipo Date
-
Market Cap
1357215948800
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
794900000
Cost Of Revenue
14000000
Gross Profit
780900000
Operating Expenses
541900000
Operating Income
239000000
Interest Expense
-
Pretax Income
291800000
Net Income
209500000
Eps
2.0439024390243903
Dividends Per Share
-
Shares Outstanding
90682200
Income Tax Expense
82300000
EBITDA
299500000
Operating Margin
30.066675053465847
Total Other Income Expense Net
52800000
Cash
340200000
Short Term Investments
774600000
Receivables
728000000
Inventories
69300000
Total Current Assets
2158400000
Property Plant Equipment
566200000
Total Assets
4265700000
Payables
119900000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1262100000
Equity
3003600000
Bs_currency_symbol
-
Depreciation
7700000
Change In Working Capital
62800000
Cash From Operations
227500000
Capital Expenditures
13200000
Cash From Investing
-196700000
Cash From Financing
45600000
Net Change In Cash
76200000
Cf_currency_symbol
-
PE
1.8892
PB
4.768386269809561
ROE
6.974963377280597
ROA
4.911268959373608
FCF
214300000
Fcf Percent
0.26959365957982134
Piotroski FScore
4
Health Score
75
Deep Value Investing Score
7.5
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
9
Garp Investing Score
7.5
Growth Investing Score
6
Momentum Investing Score
6.5
Net Net Investing Score
4
Quality Investing Score
8.5
Value Investing Score
8.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
794900000
Quarters > 0 > income Statement > cost Of Revenue
14000000
Quarters > 0 > income Statement > gross Profit
780900000
Quarters > 0 > income Statement > operating Expenses
541900000
Quarters > 0 > income Statement > operating Income
239000000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
291800000
Quarters > 0 > income Statement > net Income
209500000
Quarters > 0 > income Statement > eps
2.0439024390243903
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
102500000
Quarters > 0 > income Statement > income Tax Expense
82300000
Quarters > 0 > income Statement > EBITDA
299500000
Quarters > 0 > income Statement > operating Margin
30.066675053465847
Quarters > 0 > income Statement > total Other Income Expense Net
52800000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
340200000
Quarters > 0 > balance Sheet > short Term Investments
774600000
Quarters > 0 > balance Sheet > receivables
728000000
Quarters > 0 > balance Sheet > inventories
69300000
Quarters > 0 > balance Sheet > total Current Assets
2158400000
Quarters > 0 > balance Sheet > property Plant Equipment
566200000
Quarters > 0 > balance Sheet > total Assets
4265700000
Quarters > 0 > balance Sheet > payables
119900000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1262100000
Quarters > 0 > balance Sheet > equity
3003600000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
209500000
Quarters > 0 > cash Flow > depreciation
7700000
Quarters > 0 > cash Flow > change In Working Capital
62800000
Quarters > 0 > cash Flow > cash From Operations
227500000
Quarters > 0 > cash Flow > capital Expenditures
13200000
Quarters > 0 > cash Flow > cash From Investing
-196700000
Quarters > 0 > cash Flow > cash From Financing
45600000
Quarters > 0 > cash Flow > net Change In Cash
76200000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
2.0439024390243903
Quarters > 0 > ratios > PB
4.768386269809561
Quarters > 0 > ratios > ROE
6.974963377280597
Quarters > 0 > ratios > ROA
4.911268959373608
Quarters > 0 > ratios > FCF
214300000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.26959365957982134
Quarters > 0 > health Score
75
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
687500000
Quarters > 1 > income Statement > cost Of Revenue
11300000
Quarters > 1 > income Statement > gross Profit
676200000
Quarters > 1 > income Statement > operating Expenses
530600000
Quarters > 1 > income Statement > operating Income
145600000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
159500000
Quarters > 1 > income Statement > net Income
107500000
Quarters > 1 > income Statement > eps
1.0643564356435644
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
101000000
Quarters > 1 > income Statement > income Tax Expense
52000000
Quarters > 1 > income Statement > EBITDA
152900000
Quarters > 1 > income Statement > operating Margin
21.17818181818182
Quarters > 1 > income Statement > total Other Income Expense Net
13900000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
264000000
Quarters > 1 > balance Sheet > short Term Investments
711600000
Quarters > 1 > balance Sheet > receivables
595700000
Quarters > 1 > balance Sheet > inventories
56900000
Quarters > 1 > balance Sheet > total Current Assets
1748900000
Quarters > 1 > balance Sheet > property Plant Equipment
584000000
Quarters > 1 > balance Sheet > total Assets
3889800000
Quarters > 1 > balance Sheet > payables
104600000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1195500000
Quarters > 1 > balance Sheet > equity
2694300000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
107500000
Quarters > 1 > cash Flow > depreciation
7300000
Quarters > 1 > cash Flow > change In Working Capital
-39100000
Quarters > 1 > cash Flow > cash From Operations
102000000
Quarters > 1 > cash Flow > capital Expenditures
12500000
Quarters > 1 > cash Flow > cash From Investing
-29000000
Quarters > 1 > cash Flow > cash From Financing
-3300000
Quarters > 1 > cash Flow > net Change In Cash
69900000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
1.0643564356435644
Quarters > 1 > ratios > PB
5.237995026537505
Quarters > 1 > ratios > ROE
3.989904613443195
Quarters > 1 > ratios > ROA
2.7636382333281917
Quarters > 1 > ratios > FCF
89500000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.13018181818181818
Quarters > 1 > health Score
62
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
572600000
Quarters > 2 > income Statement > cost Of Revenue
9200000
Quarters > 2 > income Statement > gross Profit
563400000
Quarters > 2 > income Statement > operating Expenses
539800000
Quarters > 2 > income Statement > operating Income
23600000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
14700000
Quarters > 2 > income Statement > net Income
7900000
Quarters > 2 > income Statement > eps
0.07707317073170732
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
102500000
Quarters > 2 > income Statement > income Tax Expense
6800000
Quarters > 2 > income Statement > EBITDA
31300000
Quarters > 2 > income Statement > operating Margin
4.121550820817324
Quarters > 2 > income Statement > total Other Income Expense Net
-8900000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
194100000
Quarters > 2 > balance Sheet > short Term Investments
749400000
Quarters > 2 > balance Sheet > receivables
516000000
Quarters > 2 > balance Sheet > inventories
59100000
Quarters > 2 > balance Sheet > total Current Assets
1637900000
Quarters > 2 > balance Sheet > property Plant Equipment
589200000
Quarters > 2 > balance Sheet > total Assets
3687700000
Quarters > 2 > balance Sheet > payables
110000000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1152000000
Quarters > 2 > balance Sheet > equity
2535700000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
7900000
Quarters > 2 > cash Flow > depreciation
7600000
Quarters > 2 > cash Flow > change In Working Capital
-23700000
Quarters > 2 > cash Flow > cash From Operations
64800000
Quarters > 2 > cash Flow > capital Expenditures
10700000
Quarters > 2 > cash Flow > cash From Investing
14200000
Quarters > 2 > cash Flow > cash From Financing
-117900000
Quarters > 2 > cash Flow > net Change In Cash
-38900000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.07707317073170732
Quarters > 2 > ratios > PB
5.64827266632488
Quarters > 2 > ratios > ROE
0.3115510509918366
Quarters > 2 > ratios > ROA
0.2142256691162513
Quarters > 2 > ratios > FCF
54100000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.09448131330771918
Quarters > 2 > health Score
54
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
627700000
Quarters > 3 > income Statement > cost Of Revenue
9300000
Quarters > 3 > income Statement > gross Profit
618400000
Quarters > 3 > income Statement > operating Expenses
476400000
Quarters > 3 > income Statement > operating Income
142000000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
162600000
Quarters > 3 > income Statement > net Income
103100000
Quarters > 3 > income Statement > eps
1.0019436345966959
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
102900000
Quarters > 3 > income Statement > income Tax Expense
59500000
Quarters > 3 > income Statement > EBITDA
181700000
Quarters > 3 > income Statement > operating Margin
22.622271785884976
Quarters > 3 > income Statement > total Other Income Expense Net
20600000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
233000000
Quarters > 3 > balance Sheet > short Term Investments
843100000
Quarters > 3 > balance Sheet > receivables
479100000
Quarters > 3 > balance Sheet > inventories
57400000
Quarters > 3 > balance Sheet > total Current Assets
1724700000
Quarters > 3 > balance Sheet > property Plant Equipment
592000000
Quarters > 3 > balance Sheet > total Assets
3718700000
Quarters > 3 > balance Sheet > payables
110000000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1129000000
Quarters > 3 > balance Sheet > equity
2589700000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
103100000
Quarters > 3 > cash Flow > depreciation
7100000
Quarters > 3 > cash Flow > change In Working Capital
94300000
Quarters > 3 > cash Flow > cash From Operations
242500000
Quarters > 3 > cash Flow > capital Expenditures
7300000
Quarters > 3 > cash Flow > cash From Investing
-68300000
Quarters > 3 > cash Flow > cash From Financing
-290000000
Quarters > 3 > cash Flow > net Change In Cash
-116100000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
1.0019436345966959
Quarters > 3 > ratios > PB
5.552078232999961
Quarters > 3 > ratios > ROE
3.981156118469321
Quarters > 3 > ratios > ROA
2.7724742517546455
Quarters > 3 > ratios > FCF
235200000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.37470129042536243
Quarters > 3 > health Score
70
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2355300000
Annuals > 0 > income Statement > cost Of Revenue
34000000
Annuals > 0 > income Statement > gross Profit
2321300000
Annuals > 0 > income Statement > operating Expenses
1750800000
Annuals > 0 > income Statement > operating Income
570500000
Annuals > 0 > income Statement > interest Expense
126600000
Annuals > 0 > income Statement > pretax Income
486000000
Annuals > 0 > income Statement > net Income
341300000
Annuals > 0 > income Statement > eps
3.29122468659595
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
103700000
Annuals > 0 > income Statement > income Tax Expense
144700000
Annuals > 0 > income Statement > EBITDA
639700000
Annuals > 0 > income Statement > operating Margin
24.221967477603705
Annuals > 0 > income Statement > total Other Income Expense Net
-84500000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
233000000
Annuals > 0 > balance Sheet > short Term Investments
843100000
Annuals > 0 > balance Sheet > receivables
479100000
Annuals > 0 > balance Sheet > inventories
57400000
Annuals > 0 > balance Sheet > total Current Assets
1724700000
Annuals > 0 > balance Sheet > property Plant Equipment
592000000
Annuals > 0 > balance Sheet > total Assets
3718700000
Annuals > 0 > balance Sheet > payables
110000000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1129000000
Annuals > 0 > balance Sheet > equity
2589700000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
341300000
Annuals > 0 > cash Flow > depreciation
27100000
Annuals > 0 > cash Flow > change In Working Capital
-19200000
Annuals > 0 > cash Flow > cash From Operations
595400000
Annuals > 0 > cash Flow > capital Expenditures
38200000
Annuals > 0 > cash Flow > cash From Investing
-126800000
Annuals > 0 > cash Flow > cash From Financing
-486700000
Annuals > 0 > cash Flow > net Change In Cash
-18100000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
3.29122468659595
Annuals > 0 > ratios > PB
5.595243078348843
Annuals > 0 > ratios > ROE
13.179132718075454
Annuals > 0 > ratios > ROA
9.177938526904564
Annuals > 0 > ratios > FCF
557200000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.2365728357321785
Annuals > 0 > health Score
84
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1887100000
Annuals > 1 > income Statement > cost Of Revenue
39700000
Annuals > 1 > income Statement > gross Profit
1847400000
Annuals > 1 > income Statement > operating Expenses
1596500000
Annuals > 1 > income Statement > operating Income
250900000
Annuals > 1 > income Statement > interest Expense
4600000
Annuals > 1 > income Statement > pretax Income
332100000
Annuals > 1 > income Statement > net Income
249700000
Annuals > 1 > income Statement > eps
2.4722772277227723
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
101000000
Annuals > 1 > income Statement > income Tax Expense
82400000
Annuals > 1 > income Statement > EBITDA
416100000
Annuals > 1 > income Statement > operating Margin
13.295532828149012
Annuals > 1 > income Statement > total Other Income Expense Net
81200000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
251100000
Annuals > 1 > balance Sheet > short Term Investments
780500000
Annuals > 1 > balance Sheet > receivables
439300000
Annuals > 1 > balance Sheet > inventories
38300000
Annuals > 1 > balance Sheet > total Current Assets
1607000000
Annuals > 1 > balance Sheet > property Plant Equipment
347300000
Annuals > 1 > balance Sheet > total Assets
3251400000
Annuals > 1 > balance Sheet > payables
133300000
Annuals > 1 > balance Sheet > short Term Debt
170100000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1019400000
Annuals > 1 > balance Sheet > equity
2232000000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
249700000
Annuals > 1 > cash Flow > depreciation
21300000
Annuals > 1 > cash Flow > change In Working Capital
28200000
Annuals > 1 > cash Flow > cash From Operations
389900000
Annuals > 1 > cash Flow > capital Expenditures
28300000
Annuals > 1 > cash Flow > cash From Investing
-467100000
Annuals > 1 > cash Flow > cash From Financing
65300000
Annuals > 1 > cash Flow > net Change In Cash
-11600000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
2.4722772277227723
Annuals > 1 > ratios > PB
6.32290770609319
Annuals > 1 > ratios > ROE
11.187275985663083
Annuals > 1 > ratios > ROA
7.67976871501507
Annuals > 1 > ratios > FCF
361600000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.19161676646706588
Annuals > 1 > health Score
77
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1488700000
Annuals > 2 > income Statement > cost Of Revenue
23200000
Annuals > 2 > income Statement > gross Profit
1465500000
Annuals > 2 > income Statement > operating Expenses
1216500000
Annuals > 2 > income Statement > operating Income
249000000
Annuals > 2 > income Statement > interest Expense
7100000
Annuals > 2 > income Statement > pretax Income
213900000
Annuals > 2 > income Statement > net Income
154500000
Annuals > 2 > income Statement > eps
1.5621840242669363
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
98900000
Annuals > 2 > income Statement > income Tax Expense
59400000
Annuals > 2 > income Statement > EBITDA
264600000
Annuals > 2 > income Statement > operating Margin
16.726002552562637
Annuals > 2 > income Statement > total Other Income Expense Net
-35100000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
262900000
Annuals > 2 > balance Sheet > short Term Investments
726400000
Annuals > 2 > balance Sheet > receivables
350000000
Annuals > 2 > balance Sheet > inventories
35100000
Annuals > 2 > balance Sheet > total Current Assets
1453500000
Annuals > 2 > balance Sheet > property Plant Equipment
145600000
Annuals > 2 > balance Sheet > total Assets
2368700000
Annuals > 2 > balance Sheet > payables
67300000
Annuals > 2 > balance Sheet > short Term Debt
169400000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
660900000
Annuals > 2 > balance Sheet > equity
1707800000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
154500000
Annuals > 2 > cash Flow > depreciation
15600000
Annuals > 2 > cash Flow > change In Working Capital
-67400000
Annuals > 2 > cash Flow > cash From Operations
339400000
Annuals > 2 > cash Flow > capital Expenditures
16500000
Annuals > 2 > cash Flow > cash From Investing
-177100000
Annuals > 2 > cash Flow > cash From Financing
-234300000
Annuals > 2 > cash Flow > net Change In Cash
-73300000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
1.5621840242669363
Annuals > 2 > ratios > PB
8.091870827965804
Annuals > 2 > ratios > ROE
9.046726782995666
Annuals > 2 > ratios > ROA
6.522565120108076
Annuals > 2 > ratios > FCF
322900000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.21690065157519983
Annuals > 2 > health Score
75
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1133500000
Annuals > 3 > income Statement > cost Of Revenue
14300000
Annuals > 3 > income Statement > gross Profit
1119200000
Annuals > 3 > income Statement > operating Expenses
1016700000
Annuals > 3 > income Statement > operating Income
102500000
Annuals > 3 > income Statement > interest Expense
25800000
Annuals > 3 > income Statement > pretax Income
101400000
Annuals > 3 > income Statement > net Income
89600000
Annuals > 3 > income Statement > eps
0.9152196118488254
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
97900000
Annuals > 3 > income Statement > income Tax Expense
11800000
Annuals > 3 > income Statement > EBITDA
138100000
Annuals > 3 > income Statement > operating Margin
9.042787825319806
Annuals > 3 > income Statement > total Other Income Expense Net
-1100000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
340800000
Annuals > 3 > balance Sheet > short Term Investments
370500000
Annuals > 3 > balance Sheet > receivables
185500000
Annuals > 3 > balance Sheet > inventories
30500000
Annuals > 3 > balance Sheet > total Current Assets
972800000
Annuals > 3 > balance Sheet > property Plant Equipment
155800000
Annuals > 3 > balance Sheet > total Assets
2072500000
Annuals > 3 > balance Sheet > payables
51500000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
698500000
Annuals > 3 > balance Sheet > equity
1374000000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
89600000
Annuals > 3 > cash Flow > depreciation
10900000
Annuals > 3 > cash Flow > change In Working Capital
16700000
Annuals > 3 > cash Flow > cash From Operations
256500000
Annuals > 3 > cash Flow > capital Expenditures
23400000
Annuals > 3 > cash Flow > cash From Investing
-130200000
Annuals > 3 > cash Flow > cash From Financing
27400000
Annuals > 3 > cash Flow > net Change In Cash
153700000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.9152196118488254
Annuals > 3 > ratios > PB
9.95601673944687
Annuals > 3 > ratios > ROE
6.521106259097525
Annuals > 3 > ratios > ROA
4.3232810615199035
Annuals > 3 > ratios > FCF
233100000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.20564622849580944
Annuals > 3 > health Score
66
Valuation > metrics > PE
1.8892
Valuation > metrics > PB
4.768386269809561
Valuation > final Score
52.31613730190439
Valuation > verdict
11.1% Undervalued
Profitability > metrics > ROE
6.974963377280597
Profitability > metrics > ROA
9.70626389918458
Profitability > metrics > Net Margin
0.2635551641715939
Profitability > final Score
73
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.4201957650819017
Risk > metrics > Interest Coverage
31.038961038961038
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
18.001668056713928
Liquidity > metrics > Quick Ratio
17.423686405337783
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
47.62004973462495
Prev Valuations > 1
43.5172733367512
Prev Valuations > 2
44.47921767000039
Prev Profitabilities > 0
50
Prev Profitabilities > 1
4
Prev Profitabilities > 2
51
Prev Risks > 0
100
Prev Risks > 1
66
Prev Risks > 2
90
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:13:52.988Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-05
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
2.41
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy and schizophrenia; NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Neurocrine Biosciences, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
2.41
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.